71.84
-0.64 (-0.88%)
| Previous Close | 72.48 |
| Volume | 1,061,287 |
| Price / Earnings (Forward) | 15.17 |
| Price / Sales | 1.61 |
| Price / Book | 3.08 |
| 52 Weeks Range | |
| TTM Dividend Yield | 0.20% |
| Profit Margin | 11.03% |
| Operating Margin (TTM) | 14.78% |
| Diluted EPS (TTM) | 4.76 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Quarterly Earnings Growth (YOY) | 50.80% |
| Total Debt/Equity (MRQ) | 97.51% |
| Current Ratio (MRQ) | 0.980 |
| Operating Cash Flow (TTM) | 1.78 B |
| Levered Free Cash Flow (TTM) | 1.58 B |
| Return on Assets (TTM) | 5.87% |
| Return on Equity (TTM) | 26.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | GE HealthCare Technologies Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | 1.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 2.0 |
| Average | 0.67 |
|
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%). |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Core |
| % Held by Insiders | 0.28% |
| % Held by Institutions | 80.26% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| HOLTON ADAM Y | - | 73.69 | -1,360 | -100,218 |
| Aggregate Net Quantity | -1,360 | |||
| Aggregate Net Value ($) | -100,218 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 73.69 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| HOLTON ADAM Y | Officer | 15 Aug 2026 | Disposed (-) | 1,360 | 73.69 | 100,218 |
| TTM Dividend Yield | 0.20% |
| 3Y Average Dividend Yield | 0.15% |
| Payout Ratio | 2.63% |
| Expected Next Dividend Payment | Feb 2027 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 24 Jul 2026 | 30 Jun 2026 | 14 Aug 2026 | 0.035 Cash |
| 02 Apr 2026 | 12 Feb 2026 | 15 May 2026 | 0.035 Cash |
| 09 Jan 2026 | 24 Nov 2025 | 13 Feb 2026 | 0.035 Cash |
| 24 Oct 2025 | 24 Sep 2025 | 14 Nov 2025 | 0.035 Cash |
| 25 Jul 2025 | 01 Jul 2025 | 15 Aug 2025 | 0.035 Cash |
| 25 Apr 2025 | 27 Mar 2025 | 15 May 2025 | 0.035 Cash |
| 14 Jan 2025 | 21 Nov 2024 | 14 Feb 2025 | 0.035 Cash |
| 18 Oct 2024 | 18 Sep 2024 | 15 Nov 2024 | 0.03 Cash |
| 19 Jul 2024 | 26 Jun 2024 | 15 Aug 2024 | 0.03 Cash |
| 18 Apr 2024 | 22 Mar 2024 | 15 May 2024 | 0.03 Cash |
| 12 Jan 2024 | 08 Dec 2023 | 15 Feb 2024 | 0.03 Cash |
| 19 Oct 2023 | 22 Sep 2023 | 15 Nov 2023 | 0.03 Cash |
| 20 Jul 2023 | 23 Jun 2023 | 15 Aug 2023 | 0.03 Cash |
| 22 May 2023 | 25 Apr 2023 | 15 Jun 2023 | 0.03 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2026 | 0.105 | 3 | 0.15 |
| 2025 | 0.140 | 4 | 0.17 |
| 2024 | 0.120 | 4 | 0.15 |
| 2023 | 0.090 | 3 | 0.12 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |